Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 132, Issue 1, 2006, Pages 19-24

  Wang, Steven J ^a,c   Bourguignon, Lilly Y W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c 112B ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 AMINOETHOXYDIPHENYLBORANE; CALCIUM CHANNEL BLOCKING AGENT; CISPLATIN; FURA 2 ACETOXYMETHYL ESTER; HERMES ANTIGEN; HYALURONIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MONOCLONAL ANTIBODY; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR;

ADULT; ARTICLE; CALCIUM BINDING; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CANCER GROWTH; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; HEAD CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NECK CANCER; SPECTROFLUOROMETRY;

ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CALCIUM; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; HYALURONIC ACID; IMMUNOBLOTTING; MALE; MIDDLE AGED; PHOSPHOLIPASE C; SIGNAL TRANSDUCTION; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 31144439286     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.1.19     Document Type: Article

References (27)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64.
2. Toole BP. Hyaluronan is not just a goo! J Clin Invest. 2000;106:335-336.
3. Toole BP, Hascall VC. Hyaluronan and tumor growth. Am J Pathol. 2002;161:745-747.
4. Turley E, Noble P, Bourguignon L. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277:4589-4592.
5. Carinci F, Stabellini G, Calvitti M, et al. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg. 2002;13:85-89.
6. Sato S, Miyauchi M, Takekoshi T, et al. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol. 2000;36:545-549.
7. Bourguignon LY. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001;6:287-297.
8. Franzmann E, Weed DT, Civantos F, Goodwin J, Bourguignon L. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg. 2001;124:426-432.
9. Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185HER2 and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem. 2001;276:48679-48692.
10. Wobus M, Rangwala R, Sheyn I, et al. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. Appl Immunohistochem Mol Morphol. 2002;10:34-39.
11. Singleton PA, Bourguignon LY. CD44v10 interaction with rho-kinase (ROK) activates Inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration. Cell Motil Cytoskeleton. 2002;53:293-316.
12. Singleton PA, Bourguignon LY. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. Exp Cell Res. 2004;295:102-118.
13. Bourguignon LY, Singleton PA, Diedrich F. Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-gamma promotes phospholipase C gamma1 activation, Ca (2+) signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation. J Biol Chem. 2004;279:29654-29669.
14. Thomas SM, Coppelli FM, Wells A, et al. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res. 2003;63:5629-5635.
15. Fuertesa MA, Castillab J, Alonsoa C, Perez JM. Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem. 2003;10:257-266.
16. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265-7279.
17. Stuff R, Vokes EE. Chemotherapy of head and neck tumors. In: Thawley S, Panje W, Batsakis J, Lindberg R, eds. Comprehensive Management of Head and Neck Tumors. 2nd ed. Philadelphia, Pa: WB Saunders; 1999:142.
18. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins (1,4,5)P3-induced Ca2 release. J Biochem (Tokyo). 1997;122:498-505.
19. Katakai T, Hara T, Sugai M, et al. Chemokine-independent preference for T-helper-1 cells in transendothelial migration. J Biol Chem. 2002;277:50948-50958.
20. Kokoska ER, Wolff AB, Smith GS, Miller TA. Epidermal growth factor-induced cytoprotection in human intestinal cells involves intracellular calcium signaling. J Surg Res. 2000;80:97-103.
21. Bradford CR, Zhu S, Ogawa H, et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck. 2003;25:654-661.
22. Cullen K, Newkirk K, Schumaker L, Aldosari N, Rone J, Haddad B. Glutathione S-transferase amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res. 2003;63:8097-8102.
23. Kato T, Duffey DC, Ondrey FG, et al. Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB. Head Neck. 2000;22:748-759.
24. Shiga H, Rasmussen AA, Johnston PG, et al. Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer. Head Neck. 2000;22:599-608.
25. Ghatak S, Misra S, Toole B. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem. 2003;277:38013-38020.
26. Misra S, Ghatak S, Zoltan-Jones A, Toole B. Regulation of multi-drug resistance in cancer cells by hyaluronan. J Biol Chem. 2003;278:25285-25288.
27. Bates RC, Edwards NS, Burns GF, Fisher DEA. CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res. 2001;61:5275-5283.